Over-allotment option adds $6.23 million; shares sold at $3.00
New York, July 13 – TransEnterix, Inc. said the underwriters of its recent offering of common stock partially exercised the $6.23 million over-allotment option, raising the total size to $56.23 million.
With the additional 2.08 million shares, the company has now sold a total of 18.74 million shares. The greenshoe had been for up to 2.5 million shares.
The company priced the sale at $3.00 per share on June 11.
Stifel and RBC Capital Markets were bookrunners.
Proceeds will be used for research and development, sales, marketing, and commercialization related to the company’s SurgiBot System, working capital and other general corporate purposes.
TransEntrix is a Research Triangle Park, N.C.-based medical device company that develops robotics and flexible instruments to improve minimally invasive surgery.
| Issuer: | TransEnterix, Inc.
|
| Issue: | Common shares
|
| Amount: | $56,225,001 (includes greenshoe for $6,225,000)
|
| Shares: | 18,741,667 (includes exercise of 2,075,000 shares from 2.5 million share greenshoe)
|
| Price: | $3.00
|
| Warrants: | No
|
| Pricing date: | June 11
|
| Settlement: | June 17 for original shares, July 10 for greenshoe
|
| Bookrunners: | Stifel, RBC Capital Markets
|
| Co-managers: | Raymond James, BTIG, Ladenburg Thalmann
|
| Stock symbol: | NYSE MKT: TRXC
|
| Stock price: | $3.14 at close on June 11, $2.90 at close on July 10
|
| Market capitalization: | $236 million
|
|
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
